Drug Type Small molecule drug |
Synonyms BI 1819479 |
Target- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Idiopathic Pulmonary Fibrosis | Phase 2 | US | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | CN | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | JP | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | AU | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | AT | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | BE | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | DK | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | FI | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | FR | 22 Aug 2024 | |
Idiopathic Pulmonary Fibrosis | Phase 2 | DE | 22 Aug 2024 |